Trial
NCT00875004
Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Collaborators
—
Condition
Anemia
Intervention
epoetin beta
Why stopped
After two years of trial initiation, only 27 out of 300 patients were included. During this period, the international recommendations for the use of COOL were modified.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-26